Izotropic Corporation
Izotropic Corporation, a research and development company, develops diagnostic products for detecting breast cancers. The company develops and commercializes IzoView, a CT diagnostic imaging device with a platform of targeted uses offering high resolution, true 3D dedicated breast imaging with 360-degree image acquisition and can be used with or without injectable contrast. Izotropic Corporation … Read more
Market Cap & Net Worth: Izotropic Corporation (IZOZF)
Izotropic Corporation (OTCQB:IZOZF) has a market capitalization of $14.78 Million ($14.78 Million) as of March 19, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #27193 globally and #9122 in its home market, demonstrating a -8.79% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Izotropic Corporation's stock price $0.22 by its total outstanding shares 67784679 (67.78 Million).
Izotropic Corporation Market Cap History: 2019 to 2025
Izotropic Corporation's market capitalization history from 2019 to 2025. Data shows change from $11.52 Million to $14.78 Million (-3.76% CAGR).
Izotropic Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Izotropic Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of IZOZF by Market Capitalization
Companies near Izotropic Corporation in the global market cap rankings as of March 19, 2026.
Key companies related to Izotropic Corporation by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Izotropic Corporation Historical Marketcap From 2019 to 2025
Between 2019 and today, Izotropic Corporation's market cap moved from $11.52 Million to $ 14.78 Million, with a yearly change of -3.76%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $14.78 Million | +412.94% |
| 2024 | $2.88 Million | -45.51% |
| 2023 | $5.29 Million | -84.08% |
| 2022 | $33.21 Million | -33.33% |
| 2021 | $49.82 Million | -25.76% |
| 2020 | $67.11 Million | +482.35% |
| 2019 | $11.52 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Izotropic Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $14.78 Million USD |
| MoneyControl | $14.78 Million USD |
| MarketWatch | $14.78 Million USD |
| marketcap.company | $14.78 Million USD |
| Reuters | $14.78 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.